Defining the optimal interferon-stimulated genes panel to reflect serum interferon-α levels in patients with systemic lupus erythematosus

BMC Medicine · Published 2026-07-31 · DOI 10.1186/s12916-026-05102-5

Free full text

Authors (12)

Marta Rodríguez-García, Fuensanta Gómez-Bernal, Juan Carlos Quevedo-Abeledo, Beatriz Tejera-Segura, Enrique García-Barrera, Luisa María Villar, Javier Gonzalo Ocejo-Vinyals, Nerea Mota-Pérez, Javier Llorca, Raquel Largo, Miguel Angel González-Gay, Iván Ferraz-Amaro

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Rodríguez-García, M., Gómez-Bernal, F., Quevedo-Abeledo, J., et al. (2026). Defining the optimal interferon-stimulated genes panel to reflect serum interferon-α levels in patients with systemic lupus erythematosus. BMC Medicine. https://doi.org/10.1186/s12916-026-05102-5

Related articles

• A Delphi consensus recommendations from China for the management of radiation-induced hearing loss in patients with nasopharyngeal carcinoma · BMC Medicine · 2026 · Same journal
• Optimal doses of cognitive digital therapeutics for pediatric patients with cognitive impairments: A retrospective study based on big data · BMC Medicine · 2026 · Same journal
• Reduced neural sensitivity to emotional faces and voices in preterm five-year-olds: a comparative study · BMC Medicine · 2026 · Same journal
• Trimester-specific associations of maternal vitamin D metabolic markers with risks of small vulnerable newborns: a prospective birth cohort study · BMC Medicine · 2026 · Same journal
• Multimodal analysis reveals asynchronous aging dynamics between endometriosis-associated ovarian cancer and endometriosis patients · BMC Medicine · 2026 · Same journal
• The tumour microenvironment influences long-term tamoxifen benefit in postmenopausal ER+/HER2− breast cancer patients: a secondary analysis of the randomised Stockholm Tamoxifen (STO-3) trial · BMC Medicine · 2026 · Same journal
• Integrated proteomics and machine learning reveal AHNAK as a discriminative biomarker of atrial fibrillation in heart failure · BMC Medicine · 2026 · Same journal
• Comparative validation and local adaptation of gastric cancer risk assessment models in a large multicenter endoscopic screening cohort in China · BMC Medicine · 2026 · Same journal
• Circulating metabolomic signatures of ultra-processed and minimally processed food intake and risk of cardiovascular disease and type 2 diabetes: 20-year follow-up in the Whitehall II cohort · BMC Medicine · 2026 · Same journal
• Functional decline in the final years of life: A multicohort study · BMC Medicine · 2026 · Same journal